Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review.
Grace E FoxMark BernauerJennifer M StephensBianca JacksonJoshua A RothAhmed ShelbayaPublished in: ClinicoEconomics and outcomes research : CEOR (2024)
To our knowledge, this is the first study to systematically assess and create a framework for biosimilar portfolio value. The conceptual framework described here could be tested to quantify the clinical and economic value associated with a biosimilar portfolio.